PRKCB and benign prostatic hyperplasia: Quantitative analysis showed that methylation levels of ADAMTS12, CCDC181, NAALAD2, and PRKCB were significantly higher in randomly selected 15 PCa samples than 15 BPH samples (all p < 0.0500; Figure 2B).